Magnera Corp (MAGN) · Aug 6, 2026 · Earnings
Miss — GAAP EPS -$0.56 vs ~$0.31 consensus; revenue $857M vs ~$914.4M consensus
Magnera delivered higher EBITDA but missed published sales and EPS expectations, while raw-material inflation pushed full-year EBITDA guidance to its low end.
The quarter missed the market’s published benchmark by a wide margin. GAAP EPS was -$0.56 versus roughly $0.31 expected, while revenue was $857 million against approximately $914.4 million expected. The filing provides no company-specific consensus for adjusted EBITDA, so the cleanest scorecard is the revenue-and-EPS miss rather than the company’s favorable adjusted metric framing.
| Metric | Q3 2026 | Q3 2025 | Market comparison |
|---|---|---|---|
| Net sales (Key Financials) | $857M | $839M | ~$914.4M consensus |
| Operating income (Key Financials) | $22M | $13M | — |
| Adjusted EBITDA (Key Financials) | $99M | $91M | No reliable published consensus |
| Net loss (Income Statement) | $(20)M | $(18)M | — |
| Diluted EPS (Income Statement) | $(0.56) | $(0.51) | ~$0.31 consensus |
| Net cash from operating activities (Cash Flow statement, nine months) | $76M | $7M | — |
| Free cash flow (Cash Flow statement, nine months) | $32M | — | — |
Underlying operations improved, but not enough to offset the top-line shortfall. Reported sales rose just 2%, and comparable sales were flat year over year, despite 1% organic volume growth; foreign exchange contributed $21 million while lower selling prices reduced the benefit. The better operating income and 9% adjusted EBITDA growth therefore reflect cost actions and price-cost benefits more than strong underlying revenue momentum.
The forward outlook weakened rather than merely holding steady. Management reaffirmed full-year free-cash-flow expectations but moved adjusted EBITDA expectations to the low end of the prior range, citing inflation and macroeconomic uncertainty. 〔0〕 That is a negative change in earnings power even though cash generation remains supported.
The regional mix adds risk to the miss. Americas EBITDA rose 16% on a comparable basis, but Rest of World EBITDA fell 7%; the company specifically cited inflation, delayed material pass-throughs and higher selling, general and administrative costs overseas. Netting the quarter’s better cost execution against the sizable sales and EPS gap and the lower-end EBITDA outlook, this lands as a clear earnings miss.
Q4 report, late November 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!